Beyond oncology, CD147 is exploited as an entry receptor for pathogens, including SARS‐CoV‐2, HIV‐1, Plasmodium falciparum, and contributes mechanistically to cardiovascular, autoimmune, and neurodegenerative diseases. The gene discussed is BSG; the disease is neurodegenerative disease.